Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).

Bergmeijer TO, Reny JL, Pakyz RE, Gong L, Lewis JP, Kim EY, Aradi D, Fernandez-Cadenas I, Horenstein RB, Lee MTM, Whaley RM, Montaner J, Gensini GF, Cleator JH, Chang K, Holmvang L, Hochholzer W, Roden DM, Winter S, Altman RB, Alexopoulos D, Kim HS, Déry JP, Gawaz M, Bliden K, Valgimigli M, Marcucci R, Campo G, Schaeffeler E, Dridi NP, Wen MS, Shin JG, Simon T, Fontana P, Giusti B, Geisler T, Kubo M, Trenk D, Siller-Matula JM, Ten Berg JM, Gurbel PA, Hulot JS, Mitchell BD, Schwab M, Ritchie MD, Klein TE, Shuldiner AR, ICPC Investigators

Open source

DOI
10.1016/j.ahj.2017.12.010
Published
2018 Apr
Container
American heart journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ahj.2017.12.010,
  title = {Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).},
  author = {Bergmeijer TO and Reny JL and Pakyz RE and Gong L and Lewis JP and Kim EY and Aradi D and Fernandez-Cadenas I and Horenstein RB and Lee MTM and Whaley RM and Montaner J and Gensini GF and Cleator JH and Chang K and Holmvang L and Hochholzer W and Roden DM and Winter S and Altman RB and Alexopoulos D and Kim HS and Déry JP and Gawaz M and Bliden K and Valgimigli M and Marcucci R and Campo G and Schaeffeler E and Dridi NP and Wen MS and Shin JG and Simon T and Fontana P and Giusti B and Geisler T and Kubo M and Trenk D and Siller-Matula JM and Ten Berg JM and Gurbel PA and Hulot JS and Mitchell BD and Schwab M and Ritchie MD and Klein TE and Shuldiner AR and ICPC Investigators},
  year = {2018},
  journal = {American heart journal},
  doi = {10.1016/j.ahj.2017.12.010},
  url = {https://doi.org/10.1016/j.ahj.2017.12.010}
}

RIS

TY  - JOUR
TI  - Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).
AU  - Bergmeijer TO
AU  - Reny JL
AU  - Pakyz RE
AU  - Gong L
AU  - Lewis JP
AU  - Kim EY
AU  - Aradi D
AU  - Fernandez-Cadenas I
AU  - Horenstein RB
AU  - Lee MTM
AU  - Whaley RM
AU  - Montaner J
AU  - Gensini GF
AU  - Cleator JH
AU  - Chang K
AU  - Holmvang L
AU  - Hochholzer W
AU  - Roden DM
AU  - Winter S
AU  - Altman RB
AU  - Alexopoulos D
AU  - Kim HS
AU  - Déry JP
AU  - Gawaz M
AU  - Bliden K
AU  - Valgimigli M
AU  - Marcucci R
AU  - Campo G
AU  - Schaeffeler E
AU  - Dridi NP
AU  - Wen MS
AU  - Shin JG
AU  - Simon T
AU  - Fontana P
AU  - Giusti B
AU  - Geisler T
AU  - Kubo M
AU  - Trenk D
AU  - Siller-Matula JM
AU  - Ten Berg JM
AU  - Gurbel PA
AU  - Hulot JS
AU  - Mitchell BD
AU  - Schwab M
AU  - Ritchie MD
AU  - Klein TE
AU  - Shuldiner AR
AU  - ICPC Investigators
PY  - 2018
JO  - American heart journal
DO  - 10.1016/j.ahj.2017.12.010
UR  - https://doi.org/10.1016/j.ahj.2017.12.010
ER  -

APA

TO, B., JL, R., RE, P., L, G., JP, L., EY, K., D, A., I, F., RB, H., MTM, L., RM, W., J, M., GF, G., JH, C., K, C., L, H., W, H., DM, R., S, W., RB, A., D, A., HS, K., JP, D., M, G., K, B., M, V., R, M., G, C., E, S., NP, D., MS, W., JG, S., T, S., P, F., B, G., T, G., M, K., D, T., JM, S., JM, T. B., PA, G., JS, H., BD, M., M, S., MD, R., TE, K., AR, S., & Investigators, I. (2018). Genome-wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points-Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC).. American heart journal. https://doi.org/10.1016/j.ahj.2017.12.010

Source records